Featured posts

With Epidiolex, GW Pharmaceuticals Passes ‘Go’, Collects Unexpected Profits

As the U.S. Food and Drug Administration (FDA) continues to consider how to regulate cannabidiol (CBD), the one company with the green light to sell CBD as a pharmaceutical drug is raking in profits. This month, the London-based pharmaceutical company [...]

Sealed With a Curse: Uproar Over USHA Certification Prompts a Do-Over

Earlier this month, the U.S. Hemp Authority (USHA)  announced 13 companies among the first to receive the organization’s quality-assurance certification seal. Claiming to ascertain high standards and promote best practices, USHA’s Certification Program aims to provide hemp farmers, processors, customers [...]